Less than a third of regulatory actions taken by the US Food and Drug Administration (FDA) are corroborated by published research findings or public assessments, finds a study published by The BMJ today.
Oct 5, 2022
0
138
Adverse drug events (ADEs), injuries related to drug-related medical interventions, are considered some of the most prevalent types of health-care-related harm. Given that these events are costly and often morbid, artificial ...
Jan 19, 2022
0
8
The monoclonal antibodies nivolumab and ipilimumab have already undergone several early benefit assessments in various oncological indications. Since April 2021, the drug combination has also been approved for first-line ...
Oct 4, 2021
0
0
The U.S. Food and Drug Administration granted marketing authorization to the EndoRotor System, which provides a minimally invasive way to resect and remove necrotic tissue for patients with walled-off pancreatic necrosis ...
Dec 30, 2020
0
3
You generally take more medications as you get older. The doctor prescribes a statin to lower cholesterol, a steroid spray for allergies, a proton pump inhibitor for reflux, and a painkiller for the knee that's still sore ...
Sep 3, 2020
0
5
Mayo Clinic researchers and collaborators have found investigational convalescent plasma to be safe following transfusion in a diverse group of 20,000 patients. The findings—from the U.S. Food and Drug Administration's ...
Jun 19, 2020
0
0
Transferring fecal matter from the digestive systems of healthy donors to extremely ill patients who had previously been infected with drug-resistant bacteria resulted in shorter hospital stays, fewer bloodstream infections ...
Apr 30, 2020
0
2
Chloroquine, hydroxychloroquine and azithromycin are being used to treat and prevent COVID-19 despite weak evidence for effectiveness, and physicians and patients should be aware of the drugs' potentially serious adverse ...
Apr 8, 2020
0
112
(HealthDay)—Recall of a cardiac resynchronization therapy pacemaker, which occurred in November 2015, was delayed unnecessarily, according to a report published online Dec. 20 in JAMA Internal Medicine.
Dec 27, 2019
0
2
Adverse drug events could be avoided by sharing patients' medication histories and previous harmful medication exposures among various health-care facilities. That's one of the key findings of a study published today in CMAJ ...
Jul 19, 2019
0
1
